Oral GLP-1 weight loss pills could replace injections by March 2026 at $150 monthly, Medicare chief Dr. Mehmet Oz predicted in a FOX Business appearance.
A new daily oral medication, enlicitide, has shown reductions in LDL cholesterol of up to 60% in a late-stage Phase 3 trial, ...
Health and Me on MSN
Can’t Control Cholesterol With Statins? Scientists Say A New Experimental Pill Shows Strong Results
For patients whose cholesterol remains high despite statins, a new experimental daily pill, enlicitide, shows promise. Recent ...
With a snip of a gene, doctors may one day permanently lower dangerously high cholesterol, possibly removing the need for ...
Everyday Health on MSN
Experimental Obesity Drug Could Soon Compete With Wegovy and Zepbound
Drugmaker Eli Lilly said it would soon start late-stage trials for eloralintide, a drug mimicking the pancreatic hormone amylin that slows digestion and reduces hunger.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback